Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 14+
Code: NCT02877303
Phase2, Recruiting
Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
for
Lymphoma
Location: Toronto, Hamilton, London, Vancouver
Sponsor: Toronto Sunnybrook Regional Cancer Centre
Sex: All
Age: 18+
Code: NCT00363090
Phase1, Phase2, Recruiting
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
for
EBV-Related Hodgkin Lymphoma,
Location: Houston TX
Sponsor: Baylor College of Medicine
Sex: All
Age: 0+
Code: NCT04664179
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
for
Primary Malignant Peripheral Nerve Sheath Tumors
Location: Minneapolis MN
Sponsor: University of Minnesota
Sex: All
Age: 12+
Code: NCT06693284
Early_phase1, Recruiting
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
for
Follicular Lymphoma, Marginal Zone Lymphoma, B-cell Lymphoma
Location: Providence RI, New Brunswick NJ
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT04792502
Phase2, Recruiting
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
for
Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06218602
Phase2, Recruiting
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors
for
Malignant Peripheral Nerve Sheath Tumors
Location: Baltimore MD, Toronto, St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 0+
Code: NCT03141021
Recruiting
Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
for
Leukemia, Hematopoetic Stem Cell Transplantation,
Location: Tucson AZ
Sponsor: University of Arizona
Sex: All
Age: 21 - 55
Code: NCT06643221
Early_phase1, Recruiting
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders